ArticleOncotarget2017

Survival outcomes based on systemic agent used concurrently with radiation in human-papillomavirus associated oropharyngeal cancer.

Vikas Mehta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.